Neurocrine Biosciences Inc.Equity-NMS: NBIX
Equity-NMS: NBIX
$136.03
+0.45
(9:00 pm IST)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$136.03
Open
$136.03
Today’s high
$136.56
Today’s low
$134.52
52W low
$89.04
52W high
$143.35
1Y
31.94%
5Y
11.98%
PE
54.03
EPS (TTM)
2.47
Shares O/S
99.51M
Market cap
13.54B
Insights
NBIX price is above its 200 day moving average
NBIX PE is in the low end of its range over the past 2 years
NBIX PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Neurocrine Biosciences Inc.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas.

Its commercial products include INGREZZA, ALKINDI, EFMODY, Orilissa and Oriahnn. INGREZZA is marketed as DYSVAL (valbenazine) in Japan and REMLEAS (valbenazine) in other select Asian markets, where Mitsubishi Tanabe Pharma Corporation retains commercialization rights. ALKINDI is marketed as ALKINDI SPRINKLE (hydrocortisone) in the United States, where Eton Pharmaceuticals, Inc. retains commercialization rights. .


FAQs

Can I buy Neurocrine Biosciences Inc. shares in India?
How to buy Neurocrine Biosciences Inc. shares in India?
What is the share price of Neurocrine Biosciences Inc.?
What is the Market Capitalization of Neurocrine Biosciences Inc.?
What is the PE ratio of Neurocrine Biosciences Inc.?
Is Neurocrine Biosciences Inc. a good stock to buy?
In which sector / industry does Neurocrine Biosciences Inc. operate?